Insider · CIK 0001362489

Anderson Raymond

Reports to the SEC for 3 companies · WILMETTE, IL

sec.gov

Transactions

Companies

Filings

CIK

0001362489

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-25	MNPRMonopar Therapeutics · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	+1,402 sh	—	—	2,803
2026-08-25	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+1,402 sh	$30.00	+$42.1K	6,775
2026-08-25	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+1,740 sh	$30.00	+$52.2K	8,515
2026-08-25	MNPRMonopar TherapeuticsS Sale	Director	SSale	−1,802 sh	$113.05	−$204K	23,751
2026-08-25	MNPRMonopar TherapeuticsS Sale	Director	SSale	−694 sh	$110.04	−$76.4K	26,169
2026-08-25	MNPRMonopar TherapeuticsS Sale	Director	SSale	−646 sh	$111.07	−$71.8K	7,175
2026-08-25	MNPRMonopar Therapeutics · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	+1,740 sh	—	—	3,480
2026-08-25	MNPRMonopar TherapeuticsS Sale	Director	SSale	−646 sh	$110.07	−$71.1K	25,523
2026-08-25	MNPRMonopar TherapeuticsS Sale	Director	SSale	−1,802 sh	$113.05	−$204K	5,373
2026-08-25	MNPRMonopar TherapeuticsS Sale	Director	SSale	−694 sh	$110.04	−$76.4K	7,821
2025-12-02	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+2,924 sh	—	—	2,924
2025-03-04	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+11.4K sh	—	—	11,365
2023-12-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,533 sh	—	—	26,863
2023-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,533 sh	—	—	0
2023-09-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,533 sh	—	—	24,330
2023-09-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,533 sh	—	—	2,533
2023-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,534 sh	—	—	21,797
2023-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,534 sh	—	—	5,066
2023-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,533 sh	—	—	19,263
2023-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,533 sh	—	—	7,600
2023-02-01	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Director	AAward	+10.1K sh	—	—	10,133
2023-02-01	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+13.9K sh	—	—	13,930
2022-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,859 sh	—	—	0
2022-12-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,859 sh	—	—	16,730
2022-09-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,859 sh	—	—	2,859
2022-09-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,859 sh	—	—	13,871
2022-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,859 sh	—	—	5,718
2022-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,859 sh	—	—	11,012
2022-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,859 sh	—	—	8,153
2022-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,859 sh	—	—	8,577
2022-02-02	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+15.1K sh	—	—	15,128
2022-02-02	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Director	AAward	+11.4K sh	—	—	11,436
2021-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−751 sh	—	—	0
2021-12-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+751 sh	—	—	5,294
2021-09-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−751 sh	—	—	751
2021-09-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+751 sh	—	—	4,543
2021-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−752 sh	—	—	1,502
2021-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+752 sh	—	—	3,792
2021-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−751 sh	—	—	2,254
2021-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+751 sh	—	—	3,040
2021-01-26	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Director	AAward	+3,005 sh	—	—	3,005
2021-01-26	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+4,443 sh	—	—	4,443
2020-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−322 sh	—	—	0
2020-12-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+322 sh	—	—	2,289
2020-09-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+322 sh	—	—	1,967
2020-09-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−322 sh	—	—	322
2020-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−323 sh	—	—	644
2020-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+323 sh	—	—	1,645
2020-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−322 sh	—	—	967
2020-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+322 sh	—	—	1,322

Recent filings

Accepted (ET)
Aug 284/A
Anderson Raymond0001437749-26-029228
SEC(opens sec.gov)
Aug 274
Anderson Raymond0001437749-26-029115
SEC(opens sec.gov)
Dec 84
Anderson Raymond0001437749-25-037168
SEC(opens sec.gov)
Mar 74
Anderson Raymond0001437749-25-006725
SEC(opens sec.gov)
Jan 34
Anderson Raymond0001437749-24-000488
SEC(opens sec.gov)
Oct 34
Anderson Raymond0001437749-23-027582
SEC(opens sec.gov)
Jul 34
Anderson Raymond0001437749-23-019262
SEC(opens sec.gov)
Apr 44
Anderson Raymond0001437749-23-009334
SEC(opens sec.gov)

Companies

Address

1000 SKOKIE BLVD SUITE 350

WILMETTE, IL, 60091